Evolving Treatment Landscape for Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma

被引：0
|
作者：
Margaret C. Wheless [1 ]
Margaret Comer [2 ]
Michael K. Gibson [1 ]
机构：
[1] Vanderbilt University Medical Center,Department of Medicine, Division of Hematology Oncology
[2] Vanderbilt University Medical School,Vanderbilt Ingram Cancer Center
[3] Vanderbilt University Medical Center,undefined
来源：
Current Oncology Reports | 2024年 / 26卷 / 11期
关键词：
Esophageal Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Claudin18.2; FGFR; HER-2; PD-L1 Therapy;
D O I：
10.1007/s11912-024-01607-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1469 / 1488
页数：19
相关论文
共 50 条
  • [1] Treatment and outcomes of patients with advanced gastric, esophageal, or gastroesophageal junction adenocarcinoma in the United States
    Afsaneh, Barzi
    Lisa, Hess
    Zhu Yajun
    Astra, Liepa
    Fang Yun
    Craig, Kuder
    Julie, Beyrer
    Joseph, Chao
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma
    Joshi, Smita S.
    Maron, Steven B.
    Catenacci, Daniel V.
    FUTURE ONCOLOGY, 2018, 14 (05) : 417 - 430
  • [3] Propensity Matched Analysis of Surgeon-Driven Treatment Allocation for Locoregionally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma
    Zahoor, Haris
    Luketich, James D.
    Murphy, Thomas
    Gibson, Michael
    Shende, Manisha
    Winger, Dan
    Foxwell, Tyler J.
    Jobe, Blair A.
    Nason, Katie S.
    GASTROENTEROLOGY, 2012, 142 (05) : S1040 - S1040
  • [4] HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
    Li, Weiling
    Zhang, Xiaoling
    Du, Yunyi
    Zhang, Ying
    Lu, Jing
    Hu, Wenqing
    Zhao, Jun
    BIOMARKER RESEARCH, 2022, 10 (01)
  • [5] HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
    Weiling Li
    Xiaoling Zhang
    Yunyi Du
    Ying Zhang
    Jing Lu
    Wenqing Hu
    Jun Zhao
    Biomarker Research, 10
  • [6] Esophageal intramural metastasis from adenocarcinoma of the gastroesophageal junction
    Szántó, I
    Vörös, A
    Nagy, P
    Gonda, G
    Gamal, EM
    Altorjay, A
    Banai, J
    Kiss, J
    ENDOSCOPY, 2002, 34 (05) : 418 - 420
  • [7] The surgical treatment of adenocarcinoma of the gastroesophageal junction
    Gebhardt, C
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1996, : 1183 - 1183
  • [8] Treatment results of adenocarcinoma of the gastroesophageal junction
    Yonemura, Yutaka
    Kojima, Noriaki
    Kawamura, Taiiehi
    Tsukiyama, Gorou
    Bandou, Etsurou
    Sakamoto, Naoko
    Tsubosa, Yasuhiro
    Sato, Hiroshi
    HEPATO-GASTROENTEROLOGY, 2008, 55 (82-83) : 475 - 481
  • [9] Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinoma
    Pericay, Carles
    Rivera, Fernando
    Gomez-Martin, Carlos
    Nunez, Inmaculada
    Cassinello, Alejo
    Rodrigo Imedio, Esteban
    CANCER MEDICINE, 2016, 5 (12): : 3464 - 3474
  • [10] Lymph node involvement in advanced gastroesophageal junction adenocarcinoma
    Pedrazzani, Corrado
    de Manzoni, Giovanni
    Marrelli, Daniele
    Giacopuzzi, Simone
    Corso, Giovanni
    Minicozzi, Anna Maria
    Rampone, Bernardino
    Roviello, Franco
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 134 (02): : 378 - 385
12345